(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of STEAP3 mRNA] CTD PMID:31150632 1,2-dimethylhydrazine decreases expression ISO RGD:1551194 6480464 1, 2-Dimethylhydrazine results in decreased expression of STEAP3 mRNA CTD PMID:22206623 17beta-estradiol increases expression ISO RGD:1605372 6480464 Estradiol results in increased expression of STEAP3 mRNA CTD PMID:23019147 , PMID:31614463 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1551194 6480464 Tetrachlorodibenzodioxin affects the expression of STEAP3 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of STEAP3 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1551194 6480464 Tetrachlorodibenzodioxin results in decreased expression of STEAP3 mRNA CTD PMID:28213091 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1551194 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of STEAP3 mRNA CTD PMID:25975270 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:1605372 6480464 2 more ... CTD PMID:26705709 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of STEAP3 mRNA CTD PMID:21346803 2-acetamidofluorene decreases expression EXP 6480464 2-Acetylaminofluorene results in decreased expression of STEAP3 mRNA CTD PMID:22584684 2-butoxyethanol increases expression ISO RGD:1551194 6480464 n-butoxyethanol results in increased expression of STEAP3 mRNA CTD PMID:19812364 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of STEAP3 protein CTD PMID:34915118 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1605372 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of STEAP3 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of STEAP3 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1605372 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of STEAP3 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol increases expression ISO RGD:1551194 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of STEAP3 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide decreases expression ISO RGD:1551194 6480464 Fenretinide results in decreased expression of STEAP3 mRNA CTD PMID:28973697 4-nitrophenol increases expression ISO RGD:1551194 6480464 4-nitrophenol results in increased expression of STEAP3 mRNA CTD PMID:34673133 aflatoxin B1 decreases methylation ISO RGD:1605372 6480464 Aflatoxin B1 results in decreased methylation of STEAP3 gene, Aflatoxin B1 results in decreased methylation of STEAP3 intron CTD PMID:27153756 , PMID:30157460 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of STEAP3 protein CTD PMID:34116104 Aflatoxin B2 alpha decreases methylation ISO RGD:1605372 6480464 aflatoxin B2 results in decreased methylation of STEAP3 promoter CTD PMID:30157460 all-trans-retinoic acid decreases expression ISO RGD:1605372 6480464 Tretinoin results in decreased expression of STEAP3 mRNA CTD PMID:23724009 , PMID:23830798 antirheumatic drug decreases expression ISO RGD:1605372 6480464 Antirheumatic Agents results in decreased expression of STEAP3 mRNA CTD PMID:24449571 arsane affects methylation ISO RGD:1605372 6480464 Arsenic affects the methylation of STEAP3 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1605372 6480464 Arsenic affects the methylation of STEAP3 gene CTD PMID:25304211 benzene-1,2,4-triol multiple interactions ISO RGD:1605372 6480464 4-aminobenzhydrazide inhibits the reaction [hydroxyhydroquinone results in decreased expression of STEAP3 mRNA] CTD PMID:24530881 benzene-1,2,4-triol decreases expression ISO RGD:1605372 6480464 hydroxyhydroquinone results in decreased expression of STEAP3 mRNA CTD PMID:24530881 benzo[a]pyrene decreases expression ISO RGD:1605372 6480464 Benzo(a)pyrene results in decreased expression of STEAP3 mRNA CTD PMID:20064835 benzo[a]pyrene increases methylation ISO RGD:1605372 6480464 Benzo(a)pyrene results in increased methylation of STEAP3 5' UTR CTD PMID:27901495 benzo[a]pyrene decreases methylation ISO RGD:1605372 6480464 Benzo(a)pyrene results in decreased methylation of STEAP3 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1605372 6480464 Benzo(a)pyrene results in increased expression of STEAP3 mRNA CTD PMID:20106945 , PMID:26238291 benzophenone decreases expression EXP 6480464 benzophenone results in decreased expression of STEAP3 mRNA CTD PMID:22584684 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of STEAP3 mRNA CTD PMID:25181051 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of STEAP3 mRNA CTD PMID:33296240 bisphenol A increases expression ISO RGD:1551194 6480464 bisphenol A results in increased expression of STEAP3 mRNA CTD PMID:30951980 bisphenol A multiple interactions ISO RGD:1605372 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of STEAP3 mRNA CTD PMID:28628672 bisphenol F increases expression ISO RGD:1551194 6480464 bisphenol F results in increased expression of STEAP3 mRNA CTD PMID:30951980 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of STEAP3 mRNA CTD PMID:24136188 cadmium dichloride increases methylation EXP 6480464 Cadmium Chloride results in increased methylation of STEAP3 promoter CTD PMID:22457795 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of STEAP3 mRNA CTD PMID:25993096 calcitriol increases expression ISO RGD:1605372 6480464 Calcitriol results in increased expression of STEAP3 mRNA CTD PMID:26485663 capsaicin multiple interactions EXP 6480464 Capsaicin inhibits the reaction [Dietary Fats results in increased expression of STEAP3 protein] CTD PMID:20359164 carbon nanotube decreases expression ISO RGD:1551194 6480464 Nanotubes more ... CTD PMID:25620056 CGP 52608 multiple interactions ISO RGD:1605372 6480464 CGP 52608 promotes the reaction [RORA protein binds to STEAP3 gene] CTD PMID:28238834 cisplatin multiple interactions ISO RGD:1605372 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of STEAP3 mRNA CTD PMID:27392435 cobalt dichloride decreases expression ISO RGD:1605372 6480464 cobaltous chloride results in decreased expression of STEAP3 mRNA CTD PMID:19320972 , PMID:19376846 copper atom increases reduction ISO RGD:1551194 6480464 STEAP3 protein results in increased reduction of Copper CTD PMID:16609065 copper atom multiple interactions ISO RGD:1605372 6480464 [Chelating Agents binds to Copper] which results in decreased expression of STEAP3 mRNA CTD PMID:30911355 copper atom increases uptake ISO RGD:1551194 6480464 STEAP3 protein results in increased uptake of Copper CTD PMID:16609065 copper(0) increases reduction ISO RGD:1551194 6480464 STEAP3 protein results in increased reduction of Copper CTD PMID:16609065 copper(0) multiple interactions ISO RGD:1605372 6480464 [Chelating Agents binds to Copper] which results in decreased expression of STEAP3 mRNA CTD PMID:30911355 copper(0) increases uptake ISO RGD:1551194 6480464 STEAP3 protein results in increased uptake of Copper CTD PMID:16609065 copper(II) sulfate decreases expression ISO RGD:1605372 6480464 Copper Sulfate results in decreased expression of STEAP3 mRNA CTD PMID:19549813 deoxynivalenol increases phosphorylation ISO RGD:1551194 6480464 deoxynivalenol results in increased phosphorylation of STEAP3 protein CTD PMID:23811945 dexamethasone multiple interactions ISO RGD:1605372 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of STEAP3 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of STEAP3 mRNA CTD PMID:28628672 diazinon increases methylation ISO RGD:1605372 6480464 Diazinon results in increased methylation of STEAP3 gene CTD PMID:22964155 diazinon affects expression EXP 6480464 Diazinon affects the expression of STEAP3 mRNA CTD PMID:22546817 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of STEAP3 mRNA CTD PMID:22546817 diuron decreases expression EXP 6480464 Diuron results in decreased expression of STEAP3 mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO RGD:1605372 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of STEAP3 mRNA CTD PMID:29391264 entinostat increases expression ISO RGD:1605372 6480464 entinostat results in increased expression of STEAP3 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:1605372 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STEAP3 mRNA CTD PMID:27188386 ethanol increases expression ISO RGD:1551194 6480464 Ethanol results in increased expression of STEAP3 mRNA CTD PMID:30319688 formaldehyde decreases expression ISO RGD:1605372 6480464 Formaldehyde results in decreased expression of STEAP3 mRNA CTD PMID:23649840 genistein increases expression ISO RGD:1605372 6480464 Genistein results in increased expression of STEAP3 mRNA CTD PMID:23019147 indometacin multiple interactions ISO RGD:1605372 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of STEAP3 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of STEAP3 mRNA CTD PMID:28628672 iron atom affects metabolic processing ISO RGD:1551194 6480464 STEAP3 protein affects the metabolism of Iron CTD PMID:17194590 iron atom increases uptake ISO RGD:1551194 6480464 STEAP3 protein results in increased uptake of Iron CTD PMID:16609065 iron atom increases reduction ISO RGD:1551194 6480464 STEAP3 protein results in increased reduction of Iron CTD PMID:16609065 iron(0) affects metabolic processing ISO RGD:1551194 6480464 STEAP3 protein affects the metabolism of Iron CTD PMID:17194590 iron(0) increases uptake ISO RGD:1551194 6480464 STEAP3 protein results in increased uptake of Iron CTD PMID:16609065 iron(0) increases reduction ISO RGD:1551194 6480464 STEAP3 protein results in increased reduction of Iron CTD PMID:16609065 levofloxacin decreases expression EXP 6480464 Levofloxacin results in decreased expression of STEAP3 mRNA CTD PMID:24136188 methyl methanesulfonate decreases expression ISO RGD:1605372 6480464 Methyl Methanesulfonate results in decreased expression of STEAP3 mRNA CTD PMID:23649840 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of STEAP3 mRNA CTD PMID:24136188 nickel sulfate increases expression ISO RGD:1605372 6480464 nickel sulfate results in increased expression of STEAP3 mRNA CTD PMID:22714537 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of STEAP3 mRNA CTD PMID:24136188 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of STEAP3 mRNA CTD PMID:25729387 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of STEAP3 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1551194 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of STEAP3 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of STEAP3 mRNA CTD PMID:34911549 panobinostat multiple interactions ISO RGD:1605372 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STEAP3 mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:1605372 6480464 panobinostat results in increased expression of STEAP3 mRNA CTD PMID:26272509 paracetamol decreases expression ISO RGD:1605372 6480464 Acetaminophen results in decreased expression of STEAP3 mRNA CTD PMID:29067470 phenylmercury acetate increases expression ISO RGD:1605372 6480464 Phenylmercuric Acetate results in increased expression of STEAP3 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1605372 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STEAP3 mRNA CTD PMID:27188386 pirinixic acid multiple interactions ISO RGD:1605372 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of STEAP3 mRNA CTD PMID:19710929 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:1551194 6480464 Pregnenolone Carbonitrile results in decreased expression of STEAP3 mRNA CTD PMID:28903501 SB 431542 multiple interactions ISO RGD:1605372 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sunitinib decreases expression ISO RGD:1605372 6480464 Sunitinib results in decreased expression of STEAP3 mRNA CTD PMID:31533062 temozolomide decreases expression ISO RGD:1605372 6480464 Temozolomide results in decreased expression of STEAP3 mRNA CTD PMID:31758290 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of STEAP3 mRNA CTD PMID:31150632 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of STEAP3 mRNA] CTD PMID:31150632 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of STEAP3 mRNA CTD PMID:23411599 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of STEAP3 mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of STEAP3 mRNA CTD PMID:25729387 trichostatin A increases expression ISO RGD:1605372 6480464 trichostatin A results in increased expression of STEAP3 mRNA CTD PMID:24935251 triclosan decreases expression ISO RGD:1605372 6480464 Triclosan results in decreased expression of STEAP3 mRNA CTD PMID:30510588 triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of STEAP3 mRNA CTD PMID:30589522 triptonide decreases expression ISO RGD:1551194 6480464 triptonide results in decreased expression of STEAP3 mRNA CTD PMID:33045310 urethane decreases expression ISO RGD:1605372 6480464 Urethane results in decreased expression of STEAP3 mRNA CTD PMID:28818685 valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of STEAP3 mRNA CTD PMID:24136188 valproic acid increases expression ISO RGD:1605372 6480464 Valproic Acid results in increased expression of STEAP3 mRNA CTD PMID:24383497 more ... valproic acid multiple interactions ISO RGD:1605372 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of STEAP3 mRNA CTD PMID:27188386 vinclozolin increases methylation EXP 6480464 vinclozolin results in increased methylation of STEAP3 gene CTD PMID:31079544